Jiangsu Bioperfectus Technologies Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 4,293.49 million compared to CNY 2,171.87 million a year ago. Revenue was CNY 4,293.49 million compared to CNY 2,171.87 million a year ago.

Net income was CNY 1,624.35 million compared to CNY 996.15 million a year ago. Basic earnings per share from continuing operations was CNY 27.71 compared to CNY 16.99 a year ago. Diluted earnings per share from continuing operations was CNY 27.71 compared to CNY 16.99 a year ago.